Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

REPREXAIN Drug Profile

« Back to Dashboard
Reprexain is a drug marketed by Amneal Pharms Ny and is included in one NDA. It is available from twelve suppliers.

The generic ingredient in REPREXAIN is hydrocodone bitartrate; ibuprofen. There are twenty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the hydrocodone bitartrate; ibuprofen profile page.

Summary for Tradename: REPREXAIN

Suppliers / Packagers: see list12
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:REPREXAIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Ny
hydrocodone bitartrate; ibuprofen
TABLET;ORAL076642-003Oct 19, 2007RXNoNo► subscribe► subscribe
Amneal Pharms Ny
hydrocodone bitartrate; ibuprofen
TABLET;ORAL076642-004Oct 19, 2007RXNoNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.